Based on available data and mechanism of action, retatrutide appears most relevant for: People with significant obesity (BMI 35+) who want maximum weight reduction and haven't achieved their goals on semaglutide or tirzepatide People with type 2 diabetes who need both glycemic control and meaningful weight loss People who have plateaued on existing GLP-1 therapy and are wondering if a more powerful triple agonist would move the needle People focused on metabolic longevity , where reducing adiposity, improving insulin sensitivity, and lowering chronic inflammation are all high-priority goals If you're someone chasing a 5-10 lb cosmetic goal, retatrutide is probably overkill
Diabetes Care 41 , 10681075 (2018)
Stable drug users were defined to exclude potential confounding due to the short-term use of study drugs
The states largest health insurer on Friday reported it had an operating loss of $380.5 million for 2025, second only to the year before
Alcohol makes nausea worse
A provider that guarantees you will be approved before assessing you is telling you something important about how seriously they take the assessment